ZIONP
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/
$18.64
+0.68%
$2.7B
No data for this timeframe.
Vol
Market Cap$2.7B
Cap SizeMid Cap
SEC Reports2
Recent Activity
Jun 2, 2026
SEC
Zions Bancorporation elected Daniel J. Ryan, a retired PwC partner with over 40 years of banking and capital markets exp
8-K — Impact 2/10
Apr 20, 2026
SEC
Zions Bancorporation reported Q1 2026 earnings of $1.56 per share, a 38% year-over-year increase, driven by higher net i
8-K — Impact 8/10
Analyst Ratings
5Strong Buy
8Buy
14Hold
1Sell
0Strong Sell
Latest Reports
NEUTRAL
8-K
2/10
Zions Bancorporation elected Daniel J. Ryan, a retired PwC partner with over 40 years of banking and capital markets exp
Jun 2, 2026
BULLISH
8-K
8/10
Zions Bancorporation reported Q1 2026 earnings of $1.56 per share, a 38% year-over-year increase, driven by higher net i
Apr 20, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 46% buy across 28 analysts — 5 strong buy, 8 buy, 14 hold, 1 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 2.6% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.9B | 2.7% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.5B | 2.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $3.7B | 5.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 5 | 8 | 14 | 1 | 0 | 46% | |
| May 1, 2026 | 5 | 8 | 14 | 1 | 0 | 46% | |
| Apr 1, 2026 | 5 | 8 | 16 | 1 | 0 | 43% | |
| Mar 1, 2026 | 4 | 7 | 17 | 1 | 0 | 38% | |
| Feb 1, 2026 | 5 | 7 | 16 | 1 | 0 | 41% | |
| Jan 1, 2026 | 5 | 8 | 16 | 1 | 0 | 43% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.